Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant
Status:
Completed
Trial end date:
2018-03-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if bempedoic acid (ETC-1002) is effective and safe
versus placebo in patients with elevated LDL cholesterol and who are statin-intolerant.